Mustang Bio (MBIO) Short Interest Ratio & Short Volume $0.21 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Mustang Bio Short Interest DataMustang Bio (MBIO) has a short interest of 534,200 shares, representing 1.59% of the float (the number of shares available for trading by the public). This marks a 6.41% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 8.92 million shares to cover all short positions.Current Short Interest534,200 sharesPrevious Short Interest502,000 sharesChange Vs. Previous Month+6.41%Dollar Volume Sold Short$149,576.00Short Interest Ratio0.3 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares47,780,000 sharesFloat Size33,650,000 sharesShort Percent of Float1.59%Today's Trading Volume402,596 sharesAverage Trading Volume8,923,335 sharesToday's Volume Vs. Average5% Short Selling Mustang Bio? Sign up to receive the latest short interest report for Mustang Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMBIO Short Interest Over TimeMBIO Days to Cover Over TimeMBIO Percentage of Float Shorted Over Time Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Mustang Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024534,200 shares $149,576.00 +6.4%1.6%0.3 $0.28 10/15/2024502,000 shares $109,586.60 +31.4%1.5%0.3 $0.22 9/30/2024382,100 shares $89,908.13 -41.8%1.1%0.3 $0.24 9/15/2024656,400 shares $177,228.00 +1.3%2.0%0.2 $0.27 8/31/2024647,700 shares $182,133.24 -60.0%1.9%0 $0.28 8/15/20241,620,000 shares $607,986.00 +50.0%4.8%0.1 $0.38 Get the Latest News and Ratings for MBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mustang Bio and its competitors with MarketBeat's FREE daily newsletter. 7/31/20241,080,000 shares $362,664.00 -15.0%3.4%0 $0.34 7/15/20241,270,000 shares $502,920.00 -57.1%4.0%0 $0.40 6/30/20242,960,000 shares $1.40 million +334.7%9.4%0.1 $0.47 6/15/2024681,000 shares $88,530.00 -70.8%3.0%0 $0.13 5/31/20242,330,000 shares $468,796.00 +842.6%10.9%0.7 $0.20 5/15/2024247,200 shares $68,474.40 +200.7%2.7%0.2 $0.28 4/30/202482,200 shares $20,385.60 -39.8%0.9%0.3 $0.25 4/15/2024136,500 shares $51,187.50 -23.3%1.8%0.7 $0.38 3/31/2024178,000 shares $185,120.00 -54.2%2.4%1.2 $1.04 3/15/2024389,000 shares $369,550.00 +828.4%5.1%2.7 $0.95 2/29/202441,900 shares $56,565.00 -1.9%0.6%0.3 $1.35 2/15/202442,700 shares $55,937.00 -15.6%0.6%0.8 $1.31 1/31/202450,600 shares $72,864.00 +58.6%0.7%0.8 $1.44 1/15/202431,900 shares $46,574.00 -53.0%0.4%0.3 $1.46 12/31/202367,800 shares $91,530.00 -18.2%1.0%0.7 $1.35 12/15/202382,900 shares $114,402.00 -4.5%1.2%0.8 $1.38 11/30/202386,800 shares $124,992.00 +15.9%1.4%1 $1.44 11/15/202374,900 shares $121,338.00 -59.9%1.2%1 $1.62 10/31/2023186,700 shares $306,188.00 +571.6%2.7%2.5 $1.64 10/15/202327,800 shares $46,426.00 -53.0%0.5%1.1 $1.67 9/30/202359,200 shares $122,544.00 +166.7%1.1%2.2 $2.07 9/15/202322,200 shares $55,944.00 -59.9%0.4%0.7 $2.52 8/31/202355,400 shares $175,618.00 +60.1%1.0%1.3 $3.17 8/15/202334,600 shares $131,480.00 -19.9%0.6%0.7 $3.80 7/31/202343,200 shares $224,640.00 -45.2%0.8%0.9 $5.20 7/15/202378,800 shares $409,760.00 +47.3%1.5%1.4 $5.20 6/30/202353,500 shares $332,235.00 -19.3%1.0%0.8 $6.21 6/15/202366,300 shares $484,653.00 +10.3%1.2%0.9 $7.31 5/31/202360,100 shares $384,039.00 -38.2%1.1%1 $6.39 5/15/202397,200 shares $422,820.00 -34.7%1.8%1.9 $4.35 4/30/2023148,900 shares $631,336.00 +30.6%2.6%3.1 $4.24 4/15/2023114,000 shares $386,460.00 +850.0%2.0%2.5 $3.39 3/31/202312,000 shares $65,988.00 -91.7%0.2%0.3 $5.50 3/15/2023144,400 shares $57,528.96 -45.3%0.2%0.3 $0.40JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 2/28/2023264,000 shares $145,200.00 +3.9%0.3%0.5 $0.55 2/15/2023254,200 shares $170,288.58 -13.0%0.3%0.5 $0.67 1/31/2023292,000 shares $197,859.20 -8.5%0.4%0.6 $0.68 1/15/2023319,000 shares $202,469.30 -23.6%0.4%0.6 $0.63 12/30/2022417,700 shares $164,949.73 +4.4%0.5%0.9 $0.39 12/15/2022400,000 shares $151,200.00 +61.4%0.5%1.1 $0.38 11/30/2022247,900 shares $125,189.50 -55.6%0.3%0.7 $0.51 11/15/2022558,300 shares $267,202.38 -5.7%0.7%1.7 $0.48 10/31/2022591,800 shares $320,518.88 +33.1%0.7%1.5 $0.54 10/15/2022444,800 shares $208,833.60 -41.7%0.5%0.8 $0.47 9/30/2022762,400 shares $357,870.56 +4.1%0.9%1.4 $0.47 9/15/2022732,100 shares $427,766.03 +2.4%0.9%1 $0.58 8/31/2022714,800 shares $434,241.00 +25.2%N/A0.8 $0.61 8/15/2022570,900 shares $428,117.91 -44.6%0.7%0.6 $0.75 7/31/20221,030,000 shares $597,400.00 +14.6%1.2%1 $0.58 7/15/2022899,000 shares $557,380.00 -22.5%1.1%0.9 $0.62 6/30/20221,160,000 shares $678,600.00 -69.6%1.4%1.1 $0.59 6/15/20223,810,000 shares $2.30 million -10.4%4.5%3.4 $0.60 5/31/20224,250,000 shares $2.74 million +9.0%5.0%4.8 $0.65 5/15/20223,900,000 shares $2.70 million +3.2%4.6%4.5 $0.69 4/30/20223,780,000 shares $2.81 million +15.6%4.5%4.1 $0.74 4/15/20223,270,000 shares $2.81 million -14.6%4.0%3.3 $0.86 3/31/20223,830,000 shares $3.87 million -12.8%4.7%3.9 $1.01 3/15/20224,390,000 shares $3.35 million +16.1%5.8%4.5 $0.76 2/28/20223,780,000 shares $3.29 million -1.8%5.0%3.6 $0.87 2/15/20223,850,000 shares $3.93 million +3.2%5.1%3.4 $1.02 1/31/20223,730,000 shares $4.40 million +10.7%5.0%3.3 $1.18 1/15/20223,370,000 shares $5.06 million +13.1%9.9%3 $1.50 12/31/20212,980,000 shares $4.95 million +13.7%8.7%2.8 $1.66 12/15/20212,620,000 shares $4.90 million -3.0%7.7%2.4 $1.87 11/30/20212,700,000 shares $5.45 million -4.6%7.9%2.6 $2.02 11/15/20212,830,000 shares $6.54 million +2.9%8.3%2.9 $2.31 10/29/20212,750,000 shares $6.16 million -8.6%8.1%2.6 $2.24 10/15/20213,010,000 shares $6.89 million +2.4%8.8%2.9 $2.29 9/30/20212,940,000 shares $7.91 million -3.9%8.6%2.7 $2.69 9/15/20213,060,000 shares $8.32 million -39.6%9.0%2.6 $2.72 8/31/20215,070,000 shares $15.41 million +11.4%15.0%3.7 $3.04 8/13/20214,550,000 shares $12.42 million +15.2%13.5%2.9 $2.73 7/30/20213,950,000 shares $11.42 million +10.0%11.7%2.3 $2.89 7/15/20213,590,000 shares $10.55 million -10.5%10.6%2.1 $2.94 6/30/20214,010,000 shares $13.31 million +3.9%11.9%2.2 $3.32 6/15/20213,860,000 shares $13.78 million -17.5%11.5%2 $3.57 5/28/20214,680,000 shares $15.68 million +4.9%14.0%2.5 $3.35 5/14/20214,460,000 shares $12.04 million +6.2%13.3%2.2 $2.70 4/30/20214,200,000 shares $13.65 million -4.1%12.0%2 $3.25 4/15/20214,380,000 shares $13.93 million +13.8%12.5%1.7 $3.18 3/31/20213,850,000 shares $12.28 million +30.5%11.7%1.3 $3.19 3/15/20212,950,000 shares $10.12 million +9.7%9.0%0.9 $3.43 2/26/20212,690,000 shares $9.28 million -10.0%8.2%0.7 $3.45 2/12/20212,990,000 shares $13.19 million -11.8%9.1%0.8 $4.41JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 1/29/20213,390,000 shares $14.31 million -18.3%10.3%1 $4.22 1/15/20214,150,000 shares $19.55 million -19.6%12.6%1.3 $4.71 12/31/20205,160,000 shares $20.23 million -0.4%15.6%1.7 $3.92 12/15/20205,180,000 shares $13.99 million +14.1%15.8%2 $2.70 11/30/20204,540,000 shares $15.71 million +2.7%13.8%2.2 $3.46 11/15/20204,420,000 shares $13.48 million +3.0%13.4%2.8 $3.05 10/30/20204,290,000 shares $12.10 million +44.9%13.6%2.8 $2.82 10/15/20202,960,000 shares $9.44 million +33.3%9.4%2 $3.19 9/30/20202,220,000 shares $6.99 million +47.0%7.0%1.7 $3.15 9/15/20201,510,000 shares $5.72 million +39.8%4.8%1.2 $3.79 8/31/20201,080,000 shares $3.53 million +11.8%3.4%0.9 $3.27 8/14/2020966,300 shares $2.99 million +28.4%3.1%0.8 $3.09 7/31/2020752,500 shares $2.32 million +38.9%2.4%0.7 $3.08 7/15/2020541,600 shares $1.70 million -9.1%1.7%0.6 $3.14 6/30/2020595,900 shares $1.89 million -43.3%2.1%0.8 $3.18 6/15/20201,050,000 shares $3.31 million +297.0%3.7%1.7 $3.15 5/29/2020264,500 shares $944,265.00 +9.3%0.9%0.7 $3.57 5/15/2020241,900 shares $679,739.00 -20.2%0.9%0.7 $2.81 4/30/2020303,300 shares $864,405.00 -19.0%1.1%1.2 $2.85 4/15/2020374,400 shares $1.11 million -28.0%1.3%1.5 $2.97 3/31/2020520,200 shares $1.46 million -22.5%1.7%1.7 $2.80 3/13/2020670,800 shares $1.81 million +0.4%2.4%3.2 $2.70 2/28/2020668,400 shares $1.40 million +2.2%2.4%2 $2.09 2/14/2020653,800 shares $1.78 million -3.9%2.4%1.8 $2.73 1/31/2020680,000 shares $2.17 million +8.2%2.5%2 $3.19 1/15/2020628,600 shares $2.40 million +2.9%2.3%1.8 $3.82 12/31/2019610,700 shares $2.42 million +9.1%2.2%1.8 $3.97 MBIO Short Interest - Frequently Asked Questions What is Mustang Bio's current short interest? Short interest is the volume of Mustang Bio shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 534,200 shares of MBIO short. 1.59% of Mustang Bio's shares are currently sold short. Learn More on Mustang Bio's current short interest. What is a good short interest percentage for Mustang Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.59% of Mustang Bio's floating shares are currently sold short. Is Mustang Bio's short interest increasing or decreasing? Mustang Bio saw a increase in short interest in October. As of October 31st, there was short interest totaling 534,200 shares, an increase of 6.4% from the previous total of 502,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Mustang Bio's float size? Mustang Bio currently has issued a total of 47,780,000 shares. Some of Mustang Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mustang Bio currently has a public float of 33,650,000 shares. How does Mustang Bio's short interest compare to its competitors? 1.59% of Mustang Bio's shares are currently sold short. Here is how the short interest of companies compare to Mustang Bio: Barinthus Biotherapeutics plc (0.02%), Anebulo Pharmaceuticals, Inc. (0.12%), Lumos Pharma, Inc. (1.54%), CERo Therapeutics Holdings, Inc. (3.91%), OKYO Pharma Limited (1.11%), RAPT Therapeutics, Inc. (7.64%), Elevation Oncology, Inc. (12.42%), NextCure, Inc. (0.31%), Carisma Therapeutics, Inc. (4.00%), Lexaria Bioscience Corp. (1.72%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Mustang Bio stock? Short selling MBIO is an investing strategy that aims to generate trading profit from Mustang Bio as its price is falling. MBIO shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mustang Bio? A short squeeze for Mustang Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MBIO, which in turn drives the price of the stock up even further. How often is Mustang Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MBIO, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies BRNS Short Interest Data ANEB Short Interest Data LUMO Short Interest Data CERO Short Interest Data OKYO Short Interest Data RAPT Short Interest Data ELEV Short Interest Data NXTC Short Interest Data CARM Short Interest Data LEXX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MBIO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mustang Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mustang Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
